Surprisingly, blockade of the CXCR2 chemokine receptors, previously believed to selectively inhibit migration of neutrophils into tumors and other inflammatory tissue lesions, was shown to markedly attenuate peritumoral stromal TAN, whilst only transiently blocking the recruitment of TAN into the early tumor cell lesion. The gene discussed is CXCR2; the disease is neoplasm.